Roxas, Glore Jean V.
HRN: 12-96-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/16/2025
CEFUROXIME 500MG (TAB)
03/16/2025
03/23/2025
PO
500mg
BID
Thinly MSAF; RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes